Irritable bowel syndrome from the perspective of a clinician


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Irritable bowel syndrome (IBS) is a functional disease characterized by a stable set of intestinal symptoms in the absence of organic diseases. The main complaints of IBS patients include abdominal pain, impaired stool form and frequency, flatulence. Description of the clinical case. A clinical case of IBS with a predominance of constipation is presented. After the treatment (fractional nutrition with the introduction of an increased amount of dietary fibers and the amount of fluid taken into the diet, mebeverin + Phytomucil norn + Bac-set® Forte for 2 weeks, then Bac-set® Forte for 2 weeks), stool became formed with frequency 1 time in 2 days, the pain has disappeared, sometimes there is moderate bloating after taking carbohydrate foods in the evening, but disappears without medication overnight. During follow-up visit month after, return of symptoms was not reveal, the patient follows the regimen, diet, taking mebeverin and phytomucil on demand, rarely, according to the patient, just in case. Conclusion. The combined pathogenetic treatment of IBS with constipation, including the use of myotropic antispasmodic, natural dietary fibers and multiprobiotic, leads to a persistent clinical effect.

Full Text

Restricted Access

About the authors

A. A Samsonov

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Department of Propaedeutics of Internal Diseases and Gastroenterology Moscow, Russia

Anna G. Akselrod

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Email: anutka67@mail.ru
Dr. Sci. (Med.), Teaching Assistant at the Department of Propaedeutics of Internal Diseases and Gastroenterology, Department of Propaedeutics of Internal Medicine and Gastroenterology Moscow, Russia

Yu. S Shakh

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Department of Propaedeutics of Internal Diseases and Gastroenterology Moscow, Russia

E. V Ulyankina

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Department of Propaedeutics of Internal Diseases and Gastroenterology Moscow, Russia

References

  1. Camilleri M., Bueno L., de Ponti F., et al. Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders. Gastroenterol. 2016;150:1319-31. Doi: 10.1053/j. gastro.2005.08.062.
  2. Топчий Т.Б., Ардатская М.Д. Клиническое значение висцеральной гиперчувствительности у пациентов с СРК. Как повысить эффективность терапии болевого синдрома у пациентов с СРК. Клинический опыт применения препарата масляной кислоты закофальк в лечении синдрома раздраженной кишки. Сб. науч.-практ. статей. Под ред. М.Д. Ардатской. М., 2016.
  3. Маев И.В., Оганесян Т.С., Кучерявый Ю.А. и др. Комбинированная терапия при синдроме раздраженного кишечника: контроль моторики кишечника, кишечного транзита и висцеральной гиперчувствительности. Клинические перспективы гастроэнтерологии, гепатологии. 2015;5:45.
  4. Маев И.В., Черемушкин С.В., Кучерявый Ю.А. Синдром раздраженного кишечника. Римские критерии IV. О роли висцеральной гиперчувствительности и способах ее коррекции. М., 2016. 64 с.
  5. Ивашкин В.Т., и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по ведению пациентов с абдоминальной болью. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;25(4):71-80.
  6. Staudacher H.M., Lomer M.C.E., Farquharson F.M., et al. A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restoresbifidobacterium species: a randomized controlled trial. Gastroenterol. 2017;153(4):936-47. doi: 10.1053/j.gastro.2017.06.010.
  7. Маев И.В., Самсонов А.А., Яшина А.В. и др. Клиническая эффективность и безопасность схем лечения синдрома раздраженного кишечника (результаты сравнительного исследования). Consilium Medicum. 2016;18(8):19-26.
  8. Ishaque Sh.M., et al. A randomized placebocontrolled clinical trial of a multi-strain probiotic formulation (Bio-Kult) in the management of diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2018;18(1):71. Doi: https:// doi.org/10.1186/s12876-018-0788-9.
  9. Плотникова Е.Ю., Грачева Т.Ю., Синькова М.Н., Исаков Л.К. Роль пищевых волокон в коррекции пищеварения и запоров различной этиологии. Медицинский совет. 2019;14:99-106.
  10. WGO Practice Guideline - Constipation. URL: http:// www.worldgastroenterology.org/guidelines/global-guidelines/constipation/constipation-russian.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies